Latest Health News
Real-World Commercial Experience with Ryoncil Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
January 26, 2026 18:45 ET | Source: Mesoblast Limited NEW YORK, Jan.…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
HNL Lab Medicine Employees Select Local Charities for Annual Donation
ALLENTOWN, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine continues…
Lake Erie College of Osteopathic Medicine Designs Medical Education Around Multiple Learning Pathways to Support Different Learning Styles
Erie, PA, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Medical education is often…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
January 25, 2026 17:30 ET | Source: AVITA Medical First surgeon-reported case…
Nexalin Technology Receives Nasdaq Listing Status Notification
HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq:…
MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity
TOKYO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters:…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
